← The Wire
ABSINasdaq
Absci Corp
Services-Commercial Physical & Biological Research · CIK 1672688
Absci Corp uses AI to design and develop antibody therapeutics for unmet medical needs
$1.06B
Market cap
$11.35
Last close
+4.2%
1D
+35.1%
5D
8.1M
Volume
Price · last 39 sessions+102.0%
May 4L $4.63 · H $11.35Jun 29
109
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
8-KMaterial Agreement · Company UpdateJun 24, 2026424B5424B5Jun 24, 20268-KCompany UpdateJun 24, 20268-KShareholder VoteJun 5, 202610-Q10-QMay 7, 20268-KResults of Operations · Company UpdateMay 7, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 2026SC 13D/ASC 13D/AApr 14, 2026SC 13D/ASC 13D/AMar 26, 202610-K10-KMar 24, 20268-KResults of Operations · Company UpdateMar 24, 20268-KExecutive Change · Material AgreementMar 6, 20268-KCompany UpdateJan 14, 202610-Q10-QNov 12, 20258-KResults of Operations · Company UpdateNov 12, 20258-KMaterial AgreementNov 4, 20258-K/AResults of Operations · Company UpdateAug 12, 202510-Q10-QAug 12, 20258-KResults of Operations · Company UpdateAug 12, 2025424B5424B5Jul 25, 20258-KMaterial Agreement · Company UpdateJul 25, 2025424B5424B5Jul 24, 20258-KExecutive ChangeJul 8, 20258-KShareholder VoteJun 12, 202510-Q10-QMay 13, 20258-KResults of Operations · Company UpdateMay 13, 2025DEFA14ADEFA14AApr 28, 2025DEF 14ADEF 14AApr 28, 20258-KExecutive ChangeApr 28, 202510-K10-KMar 18, 20258-KResults of Operations · Company UpdateMar 18, 20258-KCompany UpdateJan 15, 2025SC 13GABSCI CORPORATIONNov 14, 202410-Q10-QNov 12, 20248-KResults of Operations · Company UpdateNov 12, 2024SC 13GSC 13GNov 8, 2024SC 13GSC 13GOct 18, 20248-KCompany UpdateSep 4, 202410-Q10-QAug 14, 20248-KResults of Operations · Company UpdateAug 14, 20248-KShareholder VoteJun 14, 202410-Q10-KMay 14, 20248-KResults of OperationsMay 14, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 202410-K10-KMar 21, 20248-KResults of OperationsMar 21, 20248-KMaterial Agreement · Company UpdateFeb 28, 2024424B5424B5Feb 28, 20248-KResults of Operations · Company UpdateFeb 27, 2024424B5424B5Feb 27, 2024SC 13GSC 13GFeb 13, 20248-KCompany UpdateJan 8, 20248-KCompany UpdateDec 20, 20238-KExecutive ChangeDec 7, 20238-KCompany UpdateDec 4, 202310-Q10-QNov 14, 20238-KResults of Operations · Company UpdateNov 14, 20238-KCompany UpdateSep 5, 20238-KExecutive ChangeAug 17, 20238-KExecutive Change · Results of OperationsAug 14, 202310-Q10-QAug 14, 2023424B5424B5Jun 16, 20238-KMaterial Agreement · Bylaw AmendmentJun 16, 20238-KExecutive ChangeJun 6, 202310-K/A10-K/AMay 30, 202310-Q10-QMay 15, 20238-KResults of OperationsMay 15, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 202310-K10-KMar 30, 20238-KResults of OperationsMar 30, 20238-KReg FD DisclosureMar 10, 20238-KBylaw AmendmentDec 16, 202210-Q10-QNov 9, 20228-KResults of OperationsNov 9, 20228-KExecutive ChangeNov 2, 20228-KExecutive Change · Company UpdateOct 4, 20228-KExecutive ChangeSep 20, 2022
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Mar 12, 2026: 2 insiders bought $435K · 2 sold $132K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Busch AndreasChief Innovation Officer | Buy | 100,000 | $2.29 | $229K |
| Feb 27, 2026 | Pangalos Menelas NDirector | Buy | 75,095 | $2.74 | $206K |
| Feb 2, 2026 | Mcclain SeanChief Executive Officer | Sell | 26,761 | $2.99 | $80K |
| Feb 2, 2026 | Jonasson ZachariahCFO / CBO | Sell | 17,496 | $2.99 | $52K |
| Dec 5, 2025 | Van Houten FransDirector | Buy | 40,000 | $3.72 | $149K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance